Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHavelock Europa Regulatory News (HVE)

  • There is currently no data for HVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

31 Jan 2005 16:45

Havelock Europa PLC31 January 2005 HAVELOCK EUROPA PLC31 JANUARY 2005 DEALINGS BY DIRECTORS 1) NAME OF COMPANY Havelock Europa PLC 2) NAME OF DIRECTOR Graham MacSporran 3) Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest DIRECTOR NAMED IN TWO ABOVE 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) Graham MacSporran - 124,273 ordinary shares Teawood Nominees - 93,000 ordinary shares 5) Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s) N/A 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Exercise of options over 50,000 ordinary 10p shares at an exercise price of 40.5p per share and 33,000 ordinary 10p shares at an exercise price of 29.5p per share, under the Havelock Europa PLC Executive Share Option Scheme. 7) Number of shares/amount of stock acquired 83,000 8) (%) of issued class 0.24% 9) Number of shares/amount of stock disposed N/A 10) (%)of issued class N/A 11) Class of security Ordinary 10p shares 12) Price per share N/A 13) Date of transaction 28 January 2005 14) Date company informed 28 January 2005 15) Total holding following this notification 217,273 ordinary shares 16) Total percentage holding of issued class following this notification 0.63% IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THEFOLLOWING BOXES. 17) Date of grant N/A 18) Period during which or date on which exercisable N/A 19) Total amount paid (if any) for grant of the option N/A 20) Description of shares or debentures involved: class, number N/A 21) Exercise price (if fixed at time of grant) or indication that grant isto be fixed at time of exercise N/A 22) Total number of shares or debentures over which options held following this notification 67,000 options 23) Any additional information N/A 24) Name of contact and telephone number for queries 01383 820044 25) Name and signature of authorised company official responsible for making this notification Graham MacSporran Date of notification 31 January 2005 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jul 201811:41 amRNSAppointment of Administrators & Nomad Resignation
29th Jun 20182:50 pmRNSResults of Annual General Meeting
29th Jun 20187:23 amRNSNotice of intention to appoint Administrators
27th Jun 20187:30 amRNSSuspension - Havelock Europa Plc
27th Jun 20187:30 amRNSFinance Update
31st May 20185:20 pmRNSAnnual Report and Accounts and notification of AGM
31st May 20183:46 pmRNS2017 Final Results
3rd May 201811:10 amRNSNotice of Results
1st May 201810:23 amRNSAppointment of Non-Executive Director
29th Mar 20184:10 pmRNSNotice of Results
6th Mar 20187:00 amRNSDirectorate Change
2nd Mar 20181:01 pmRNSFunding update
21st Feb 201812:42 pmRNSHolding(s) in Company
20th Feb 20187:00 amRNSCorporate Update
31st Oct 20178:49 amRNSStrategy Update
11th Oct 20175:57 pmRNSHolding(s) in Company
3rd Oct 20173:02 pmRNSHolding(s) in Company
27th Sep 20177:01 amRNSInterim results
27th Sep 20177:00 amRNSDirectorate Change
22nd Sep 20177:00 amRNSNotification of Major Interest in Shares
7th Sep 20177:00 amRNSTrading Statement
13th Jun 201712:51 pmRNSAGM Statement
13th Jun 201712:00 pmRNSAGM Statement
25th Apr 20177:00 amRNSFinal Results and New Financing Arrangements
10th Apr 201711:54 amRNSHolding(s) in Company
31st Mar 20177:00 amRNSAppointment of new Chief Financial Officer
20th Mar 20177:25 amRNSHolding(s) in Company
13th Mar 20173:25 pmRNSHolding(s) in Company
28th Feb 201711:12 amRNSFinal Results Pre-announcement
8th Feb 20172:57 pmRNSBlock Listing Six Monthly Return
1st Feb 20172:27 pmRNSHolding(s) in Company
25th Jan 201711:37 amRNSIssue of Equity
25th Jan 201710:56 amRNSNotification of Interests
25th Jan 201710:48 amRNSTrading Statement
20th Dec 20167:00 amRNSNew Chairman and proposed issue of new shares
22nd Sep 20167:00 amRNSHavelock Europa PLC Interim Results
14th Jul 20165:31 pmRNSBlocklisting Interim Review
14th Jun 20167:00 amRNSNotification of Interests - Andrew Burgess
10th Jun 20163:08 pmRNSResult of AGM
10th Jun 201612:00 pmRNSAGM Statement and Directorate Change
26th May 20167:00 amRNSHavelock Europa Annual Financial Report & Accounts
5th May 20167:00 amRNSDirector Shareholding
29th Apr 20167:00 amRNSHavelock Europa - Appointment of Non-Exec Director
14th Apr 20167:00 amRNSHavelock Europa Final Results
12th Feb 201610:15 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSHavelock Europa PLC Trading Statement
18th Dec 20157:00 amRNSHAVELOCK EUROPA APPOINTS NOMINATED ADVISER
16th Dec 20152:57 pmRNSDirectorate Change
24th Nov 20155:39 pmRNSDirector/PDMR Shareholding
17th Nov 20158:52 amRNSReplacement: Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.